Reply to Chu et al

J Infect Dis. 2023 Feb 1;227(3):466-467. doi: 10.1093/infdis/jiac310.

Authors

Bradley Ackerson¹, Katia Bruxvoort^{1

2}, Lei Qian¹, Lina S Sy¹, Hung-Fu Tseng^{1

3}

Affiliations

¹ Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
² Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
³ Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.

PMID: 35880546
DOI: 10.1093/infdis/jiac310

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

Grants and funding

GlaxoSmithKline